| Hepatocytes are resistant to cell death from canonical and non-canonical inflammasome-activated pyroptosis P Sun, J Zhong, H Liao, P Loughran, J Mulla, G Fu, D Tang, J Fan, ... Cellular and molecular gastroenterology and hepatology 13 (3), 739-757, 2022 | 26 | 2022 |
| Ten‐Eleven translocation 1 promotes malignant progression of cholangiocarcinoma with Wild‐Type isocitrate dehydrogenase 1 X Bai, H Zhang, Y Zhou, K Nagaoka, J Meng, C Ji, D Liu, X Dong, K Cao, ... Hepatology 73 (5), 1747-1763, 2021 | 22 | 2021 |
| Targeting aspartate beta-hydroxylase with the small molecule inhibitor MO-I-1182 suppresses cholangiocarcinoma metastasis K Nagaoka, K Ogawa, C Ji, KY Cao, X Bai, J Mulla, Z Cheng, JR Wands, ... Digestive Diseases and Sciences 66, 1080-1089, 2021 | 12 | 2021 |
| The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism K Nagaoka, J Mulla, K Cao, Z Cheng, D Liu, W Mueller, A Bay, ... Liver Research 4 (2), 94-100, 2020 | 9 | 2020 |
| The Role of Gasdermin-D-Mediated Pyroptosis in Organ Injury and Its Therapeutic Implications J Mulla, R Katti, MJ Scott Organogenesis 19 (1), 1-14, 2023 | 5 | 2023 |
| Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase K Nagaoka, X Bai, D Liu, K Cao, J Mulla, C Ji, H Chen, MA Nisar, A Bay, ... Cancer Letters 580, 216493, 2024 | | 2024 |
| Caspase-11 Contributes to Trauma-Induced Coagulopathy in a Murine Polytrauma Model N Alsaadi, J Mulla, Z Secunda, B Al Matour, S Abdelhamid, MJ Scott Journal of the American College of Surgeons 235 (5), S91, 2022 | | 2022 |
| The Effect of Caspase-11 in Trauma-Induced Coagulopathy (TIC) J Mulla, N Alsaadi, Z Secunday, R Katti, J Curtis, MD Neal, MJ Scott AMERICAN JOURNAL OF PATHOLOGY 192 (9), S4-S4, 2022 | | 2022 |
| Inhibition of LPS-mediated Inflammation by Intravenous Administration of a Cationic Antimicrobial Peptide in Mice J Curtis, J Mulla, Z Secunda, B AlMatour, B Deslouches, MJ Scott AMERICAN JOURNAL OF PATHOLOGY 192 (9), S6-S6, 2022 | | 2022 |
| Inhibiting TET1 alleviates non‐alcoholic liver disease progression by targeting lipid metabolic pathways. J Mulla, K Nagaoka, K Cao, Z Cheng, X Bai, H Zhang, C Ji, S Lu, ... The FASEB Journal 36, 2022 | | 2022 |
| ELEVATED 2-OXOGLUTARATE ANTAGONIZES CHEMOTHERAPEUTIC EFFECTS IN CHOLANGIOCARCINOMA BY TARGETING DNA DAMAGE RESPONSE SIGNALING PATHWAYS K Nagaoka, C Ji, X Bai, K Cao, J Mulla, A Bay, W Mueller, G Hildebrand, ... HEPATOLOGY 74, 687A-688A, 2021 | | 2021 |
| Cationic Antimicrobial Peptide, E35, Reduces LPS-induced Inflammation in Mice J Mulla, S Abdelhamid, Z Secunda, B Al Matour, N Alsaadi, B Deslouches, ... AMERICAN JOURNAL OF PATHOLOGY 191 (10 S), S8-S8, 2021 | | 2021 |
| THE 2-OXOGLUTARATE DIOXYGENASE, TET1 PROMOTES THE MALIGNANT PROGRESSION OF CHOLANGIOCARCINOMA WITH WILD-TYPE IDH1 THROUGH EPIGENETIC CONTROL X Bai, H Zhang, Y Zhou, K Nagaoka, J Meng, C Ji, D Liu, X Dong, K Cao, ... The Liver Meeting Digital Experience™, 2020 | | 2020 |
Melanie J ScottUniversity of Pittsburgh在 upmc.edu 的电子邮件经过验证
